Department of Surgery, University of Southern California, Los Angeles, California.
Division of Trauma, Burns and Surgical Critical Care, Department of Surgery, University of California, Irvine, Orange, California.
J Surg Res. 2024 Mar;295:660-665. doi: 10.1016/j.jss.2023.11.049. Epub 2023 Dec 16.
There are two zones for the placement of a Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in trauma patients: above the mesenteric vessels (Zone-1) or below the renal arteries (Zone-3). Zone-1 REBOA diverts blood away from the visceral organs which leads to a systemic inflammatory response and reperfusion injury. We hypothesized that patients undergoing Zone-1 REBOA placement had a higher odds of mortality.
The 2017-2019 Trauma Quality Improvement Program database was queried for patients undergoing either Zone-1 or Zone-3 REBOA. We excluded all patients with prehospital cardiac arrest. We compared Zone-1 versus Zone-3 REBOA using a 1:2 propensity-score model, matching for age, mechanism, sex, hypotension, tachycardia, blunt solid organ injury grade, pelvic fracture, and injuries to the aorta, iliac artery, iliac vein, and inferior vena cava.
We matched 130 Zone-1 REBOA patients to 260 Zone-3 REBOA patients. There were no statistically significant differences in the matched variables (P > 0.05). Compared to Zone-3 REBOA, patients with Zone-1 REBOA who survived ≥48 h had similar rates of acute kidney injury (18.6% versus 10.9%, P = 0.19). Zone-1 REBOA patients had a higher mortality rate (71.4% versus 48.8%, P = 0.002) and mortality odds ratio (OR) (OR 1.85, OR 1.18-2.89, P = 0.007). Zone-1 REBOA remained associated with a higher odds of mortality after controlling for traumatic brain injury and injury severity score (OR 1.86, OR 1.18-2.92, P = 0.007).
Compared to Zone-3, using a REBOA in Zone-1 is associated with higher odds of mortality. The use of REBOA Zone-1 deployment should be done with caution.
在创伤患者中,放置抢救性血管内球囊阻断主动脉(REBOA)有两个区域:肠系膜血管上方(区域 1)或肾动脉下方(区域 3)。区域 1 的 REBOA 将血液从内脏器官分流,导致全身炎症反应和再灌注损伤。我们假设接受区域 1 REBOA 放置的患者死亡率更高。
对 2017-2019 年创伤质量改进计划数据库中接受区域 1 或区域 3 REBOA 的患者进行了查询。我们排除了所有院前心脏骤停的患者。我们使用 1:2 倾向评分模型比较了区域 1 与区域 3 的 REBOA,匹配因素包括年龄、机制、性别、低血压、心动过速、钝性实体器官损伤程度、骨盆骨折以及主动脉、髂动脉、髂静脉和下腔静脉损伤。
我们将 130 例区域 1 REBOA 患者与 260 例区域 3 REBOA 患者进行了匹配。在匹配变量方面没有统计学上的显著差异(P>0.05)。与区域 3 REBOA 相比,区域 1 REBOA 中存活≥48 小时的患者急性肾损伤发生率相似(18.6%比 10.9%,P=0.19)。区域 1 REBOA 患者死亡率更高(71.4%比 48.8%,P=0.002),死亡率优势比(OR)更高(OR 1.85,OR 1.18-2.89,P=0.007)。在控制创伤性脑损伤和损伤严重程度评分后,区域 1 REBOA 与更高的死亡率相关(OR 1.86,OR 1.18-2.92,P=0.007)。
与区域 3 相比,在区域 1 使用 REBOA 与更高的死亡率相关。应谨慎使用 REBOA 区域 1 部署。